Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-04

FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for a generic omeprazole product from Lannett Company, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole (Omeprazole)

Snippet

SUPPL AP for OMEPRAZOLE (OMEPRAZOLE)